StockData
DocGo Inc. logo

DocGo Inc. (DCGO) company profile

DCGONasdaqTransportation ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3090% below fair value
$0.21−0.02 (-7.73%)

Close on Nov 13, 2026Market cap $20.54MP/E –Yield –

About DocGo

Transportation Services, SIC 4700

DocGo Inc. provides mobile healthcare and medical transportation solutions outside traditional clinical settings. The company conducts business through three segments: Mobile Health Services, Transportation Services, and Corporate. Its Mobile Health Services segment delivers on-site evaluation, diagnostics, triage, chronic condition monitoring, and gap closure services to patients in residences, workplaces, and community environments. Under the Ambulnz brand, the Transportation Services segment operates digitally enabled medical transport and ambulance transfers integrated with hospital record systems. DocGo serves diverse customers, including municipalities, hospital systems, health insurance providers, employers, physician practices, and government entities.

DocGo operates across all 50 U.S. states and within the United Kingdom. Its medical fleet comprises 582 vehicles deployed in the United States and 288 vehicles serving the United Kingdom. The organization employs nearly 3,600 personnel, including field healthcare clinicians, management staff, and corporate personnel, supplemented by over 800 subcontracted workers and independent contractors. The provided text does not mention the location of the company's corporate headquarters.

Summary of the business section of DocGo's latest annual report, written by StockData.

Company profile

Company

Legal name
DocGo Inc.
Founded
2015
Headquarters
New York, NY
Address
685 Third Avenue, 9th Floor 10017
Phone
(844) 443-6246
Website
docgo.com
Employees
3,600, Dec 31, 2025
Industry
Transportation Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Urish Popeck & Co., LLC, Pittsburgh, PA

Stock & identifiers

Ticker
DCGO
Former tickers
MOTN until Nov 12, 2021
Exchange
Nasdaq
IPO date
Oct 16, 2020
Shares outstanding
99M, Aug 14, 2026
Public float
$149.56M, Jun 30, 2025
Filer category
Accelerated filer<br>Smaller reporting company
SEC CIK
1822359
CUSIP
256086109
ISIN
US2560861096
FIGI
BBG00YB8JBK8
Share class FIGI
BBG00YB8JBL7
EIN
85-2515483

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Lee BienstockChief Executive Officer, Director2,801,826
Ely D. TendlerGeneral Counsel and Secretary, Director258,795
Norman RosenbergCFO and Treasurer1,223,571
Stephen SugrueChief Compliance Officer636,602
Etalvina LeiteDirector201,411
Michael J. BurdiekDirector3,364,773
James M. TraversDirector632,027
Ira SmedraDirector240,999
Stephen K. M.D. KlaskoDirector115,000

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$3.57M-$1.14M$1.51M$12–
FY2024
Lee Bienstock
$7.56M$4.01M$2.66M$60–
FY2024
Mr Bienstock
$7.56M$4.01M$2.66M$60–
FY2023
Anthony Capone
$928.90K-$1.20M$3.13M$79–
FY2023
Lee Bienstock
$11.35M$10.91M$3.13M$79–
FY2023
Mr Bienstock
$11.35M$10.91M$3.13M$79–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Lee Bienstock
Chief Executive Officer
$785.00K$1.93M$831.32K$29.29K$3.57M-53%
Norman Rosenberg
Chief Financial Officer and Treasurer
$492.00K$742.87K$432.45K$29.29K$1.70M-65%
Ely D. Tendler
General Counsel, Secretary and Director
–$92.00K–$1.23M$1.32M-3%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Oct 16, 2020
Offer price
$10.00
Securities offered
11,500,000
Gross proceeds
$115.00M
Exchange
Nasdaq
First trading day
Dec 11, 2020
First-day close
$12.45+24.5%
Lock-up ends (est.)
Jun 9, 2021

“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one - third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had nearly 3,600 employees, including healthcare professionals, field management personnel and corporate support staff, as represented in the table below.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?